efficaci
antiinflammatori
drug
experiment
infect
cryptosporidium
parvum
evalu
neonat
lamb
anim
treat
oral
administr
drug
mgkg
bodi
weight
prophylact
therapeut
treatment
start
h
inocul
lamb
oocyst
continu
eight
consecut
day
therapeut
treatment
initi
onset
diarrhoea
confirm
infect
continu
six
consecut
day
infect
monitor
daili
examin
faecal
sampl
first
day
day
postinocul
criteria
consid
evalu
develop
infect
drug
activ
oocyst
shed
presenc
diarrhoea
weight
gain
day
postinocul
effect
prophylactictherapeut
treatment
lowest
dose
mgkg
bodi
weight
group
treat
dose
drug
longer
prepat
period
shorter
patent
period
lower
intens
oocyst
excret
untreat
control
group
differ
statist
signific
p
moreov
one
anim
excret
oocyst
two
lamb
diarrhoea
day
group
treat
higher
dose
drug
diarrhoea
last
significantli
shorter
period
p
untreat
group
cryptosporidiosi
produc
cryptosporidium
parvum
consid
seriou
enter
diseas
caus
diarrhoea
dehydr
weight
loss
sometim
death
livestock
fayer
ungar
de
graaf
et
al
neonat
lamb
prepat
period
last
approxim
day
clinic
symptom
appar
day
week
promin
symptom
mildtosever
diarrhoea
clinic
sign
includ
depress
anorexia
abdomin
pain
larg
number
oocyst
oocystsg
present
diarrhoeat
stool
weight
loss
mortal
associ
diseas
may
induc
import
econom
loss
farmer
et
al
sporozoit
c
parvum
attach
intestin
epithelium
follow
excyst
specif
molecul
surfac
epitheli
cell
c
parvum
sporozoit
involv
infect
process
wwwelseviercomlocatevetpar
avail
onlin
wwwsciencedirectcom
veterinari
parasitolog
presenc
c
parvum
sporozoit
surfac
lectin
specif
galactosenacetylgalactosamin
galgalnac
may
mediat
attach
sporozoit
host
cell
demonstr
chen
larusso
mani
drug
test
date
halofuginon
lactat
paromomycin
cyclodextrin
mancassola
et
al
chartier
et
al
chartier
et
al
viu
et
al
castrohermida
et
al
shown
partial
effect
treatment
prophylaxi
cryptosporidiosi
neonat
lamb
goat
kid
moreov
cryptosporidiosi
difficult
control
resist
oocyst
environment
condit
disinfect
includ
sodium
hypochlorit
ammonia
chlorin
hydrogen
peroxid
glutaraldehyd
formaldehyd
korich
et
al
castrohermida
et
al
infect
c
parvum
demonstr
increas
concentr
tissu
prostaglandin
pig
calv
human
argenzio
et
al
laurent
et
al
cole
et
al
prostaglandin
produc
integr
part
inflammatori
respons
infect
inhibit
sodium
absorpt
blockad
nonspecif
cyclooxygenas
cox
inhibitor
indomethacin
restor
sodium
absorpt
normal
level
argenzio
et
al
drug
obtain
chemic
synthesi
shown
potenti
activ
antiinflammatori
agent
action
similar
superior
nonsteroid
antiinflammatori
drug
et
al
et
al
interest
properti
phenol
compound
describ
relat
structur
found
dual
inhibitor
lipooxygenas
cyclooxygenas
may
import
treatment
antiinflammatori
diseas
norton
et
al
et
al
moreov
shown
inhibitor
lselectin
express
molecul
crucial
attach
cryptosporidium
sporozoit
epitheli
cell
chen
larusso
rueda
et
al
aim
present
studi
evalu
antiparasit
activ
c
parvum
infect
neonat
lamb
oocyst
collect
natur
infect
friesian
calf
concentr
distil
water
ether
purif
discontinu
percol
gradient
quantif
neubauer
haemocytomet
oocyst
carri
describ
previous
lorenzo
et
al
isol
identifi
c
parvum
cattl
genotyp
design
genotyp
ii
c
use
procedur
amplifi
sequenc
hsp
gene
gene
cryptosporidium
xiao
et
al
lechevali
et
al
studi
carri
centro
de
investigacion
agraria
de
mabegondo
thirtyseven
newborn
male
femal
lamb
gallega
autochthon
breed
divid
random
six
group
uninfect
untreat
control
group
n
infect
treat
lamb
five
group
consist
six
anim
experiment
infect
within
h
birth
oocyst
c
parvum
suspend
ml
steril
distil
water
day
birth
inocul
prophylactictherapeut
treatment
group
treat
h
oocyst
inocul
eight
consecut
day
daili
dose
mgkg
bodi
weight
respect
therapeut
treatment
group
receiv
drug
day
follow
appar
c
parvum
oocyst
faec
daili
dose
mgkg
bodi
weight
case
powder
product
suspend
water
sodium
carboxymethyl
cellulos
tween
immedi
oral
administr
anim
excipi
control
group
receiv
excipi
sodium
carboxymethyl
cellulos
tween
suspend
water
treatment
control
group
remain
untreat
group
lamb
kept
dam
separ
box
strict
hygien
maintain
avoid
extran
infect
lamb
vaccin
receiv
vitamin
nutrit
supplement
type
medic
experi
case
ovin
cryptosporidiosi
detect
anim
maintain
mabegondo
research
centr
recent
year
anim
handl
procedur
complet
accord
institut
anim
care
use
guidelin
criteria
consid
assess
develop
infect
efficaci
treatment
oocyst
shed
presenc
diarrhoea
weight
gain
age
day
lamb
monitor
daili
birth
age
day
faecal
sampl
collect
directli
rectum
anim
steril
cotton
swab
sampl
analys
day
collect
faec
classifi
blind
fashion
accord
consist
diarrhoeaticliquid
softand
nondiarrhoeaticsolid
faecal
smear
prepar
stain
carbol
fuchsin
visual
oocyst
examin
microscopi
hein
oocyst
shed
score
semiquantit
accord
averag
number
oocyst
randomli
select
field
magnif
oocyst
oocyst
oocyst
oocyst
oocyst
comparison
mean
durat
diarrhoea
oocyst
shed
weight
birth
weight
gain
differ
group
made
pairwis
multipl
comparison
procedur
studentnewmankeul
method
oneway
analysi
varianc
graphpad
instat
window
version
graphpad
softwar
san
diego
ca
usa
differ
consid
signific
level
confid
c
parvum
detect
seven
lamb
uninfect
untreat
control
group
six
neonat
lamb
experiment
infect
untreat
group
treatment
control
began
excret
c
parvum
oocyst
age
day
intens
oocyst
shed
highest
age
day
mean
score
ae
patent
period
rang
day
ae
day
anim
develop
persist
diarrhoea
last
day
ae
day
onset
diarrhoea
coincid
start
oocyst
shed
tabl
similar
result
obtain
excipi
control
group
six
neonat
lamb
show
persist
diarrhoea
day
ae
day
onset
diarrhoea
coincid
start
oocyst
shed
age
day
patent
period
group
last
day
ae
day
oocyst
excret
reach
peak
day
began
mean
score
ae
tabl
signific
differ
treatment
control
excipi
control
group
term
criteria
studi
contrast
group
treat
prophylacticallytherapeut
mgkg
bodi
weight
three
lamb
develop
diarrhoea
two
anim
diarrhoea
last
day
respect
moreov
five
six
lamb
acquir
infect
mean
prepat
period
ae
day
last
significantli
longer
p
group
patent
period
last
day
ae
day
significantli
shorter
p
control
group
treatment
control
excipi
control
therapeut
treatment
group
mean
score
oocyst
shed
ae
significantli
lower
p
two
control
group
group
receiv
prophylactictherapeut
treatment
mgkg
bodi
weight
diarrhoea
last
maximum
day
one
lamb
develop
diarrhoea
five
remain
lamb
diarrhoea
stop
end
treatment
onset
oocyst
shed
confirm
day
age
tabl
mean
score
ae
maximum
score
record
day
age
significantli
lower
p
maximum
score
control
group
treatment
control
excipi
control
oocyst
shed
last
day
ae
day
significantli
lower
p
control
group
treatment
control
excipi
control
therapeut
treatment
group
experi
one
lamb
die
age
day
moment
lamb
excret
oocyst
diarrhoea
enteropathogen
associ
neonat
diarrhoea
rotaviru
coronaviru
escherichia
coli
clostridium
salmonella
detect
faec
lamb
treat
mgkg
bodi
weight
day
follow
confirm
infect
continu
excret
oocyst
day
ae
day
two
lamb
develop
diarrhoea
last
day
respect
tabl
none
lamb
becam
reinfect
throughout
studi
signific
differ
weight
gain
observ
age
day
tabl
period
prophylact
therapeut
treatment
group
mg
kg
gain
significantli
weight
prophylactictherapeut
treatment
group
therapeut
treatment
group
treatment
control
group
howev
gain
significantli
weight
two
control
group
uninfecteduntr
excipi
result
present
studi
clearli
show
neonat
lamb
receiv
prophylactictherapeut
treatment
mgkg
bodi
weight
appear
diarrhoea
well
durat
intens
oocyst
shed
consider
reduc
addit
oocyst
detect
one
six
lamb
remain
group
treat
sever
cryptosporidiosi
reduc
ae
ae
ae
prophylactictherapeut
treatment
mgkg
bodi
weight
ae
ae
b
ae
therapeut
treatment
mgkg
bodi
weight
ae
ae
b
ae
mean
column
differ
superscript
letter
significantli
differ
p
attach
sporozoit
epitheli
cell
invas
cell
membran
crucial
step
pathogenesi
cryptosporidiosi
galactosenacetylgalactosamin
galgalnac
epitop
glycoprotein
epitheli
apic
membran
galgalnacspecif
sporozoit
surfac
lectin
involv
mechan
previou
studi
shown
vitro
incub
c
parvum
sporozoit
galgalnac
bovin
mucin
reduc
c
parvum
attach
biliari
intestin
epithelia
preincub
cell
monolay
either
lectin
specif
galgalnac
glycosidas
specif
releas
galgalnac
oligosaccharid
glycoprotein
decreas
attach
chen
larusso
may
abl
inhibit
infect
cell
cryptosporidium
sporozoit
rueda
et
al
present
studi
abl
complet
prevent
infect
c
parvum
neonat
lamb
howev
oocyst
shed
patent
period
diarrhoea
notabl
reduc
administr
prophylactictherapeut
treatment
mg
kg
similar
result
obtain
rueda
et
al
vivo
model
chronic
cryptosporidiosi
scid
mous
c
parvum
infect
increas
concentr
tissu
prostaglandin
baselin
level
pig
human
argenzio
et
al
laurent
et
al
diarrhoea
partial
attribut
local
product
prostanoid
argenzio
et
al
argenzio
et
al
nonsteroid
antiinflammatori
drug
inhibit
synthesi
prostaglandin
thromboxan
reduct
inflamm
associ
parasit
infect
may
account
antidiarrho
effect
observ
studi
global
reduct
level
oocyst
excret
observ
may
result
anticryptosporidi
effect
drug
demonstr
vitro
rueda
et
al
nevertheless
possibl
present
studi
decreas
level
excret
due
reduc
level
diarrhoea
must
point
sign
inappet
toxic
observ
treat
anim
higher
therapeut
activ
shown
lower
dose
term
oocyst
excret
patent
period
presenc
diarrhoea
weight
gain
first
day
anim
live
may
due
low
solubl
product
amount
product
difficult
prepar
homogen
adequ
dosag
problem
solubl
bioavail
compound
previous
suggest
rueda
et
al
product
assay
treatment
cryptosporidiosi
small
rumin
halofuginon
lactat
paromomycin
sulphat
aor
bcyclodextrin
chartier
et
al
chartier
et
al
castrohermida
et
al
effect
use
prophylact
conclus
activ
demonstr
present
studi
suggest
drug
may
suitabl
use
earli
control
cryptosporidiosi
neonat
lamb
howev
studi
requir
improv
drug
formul
well
establish
optimum
dosag
durat
treatment
